Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
-
701
-
702
Figure 3 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors
Published 2025“…The pathologist conducted an overall assessment to determine whether a significant decrease was present on day 15 compared with screening biopsies.…”
-
703
-
704
Significant inter-relationships between baseline variables and MSCC or MCS.
Published 2025Subjects: -
705
Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo trypsinised with shades of green showing increase and red showing decrease with respect to soaked.
Published 2024“…<p>Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…”
-
706
-
707
-
708
DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx
Published 2024“…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”
-
709
-
710
Autophagy significantly influences the apoptotic levels of RGCs in glaucomatous mouse eyes.
Published 2024Subjects: -
711
-
712
-
713
-
714
-
715
Comparison of questionnaire scores among genotypes for the significant associations.
Published 2025Subjects: -
716
-
717
Table 1_Real-world first-line serplulimab therapy for advanced esophageal cancer: effectiveness, safety, and clinical implications.docx
Published 2025“…Only two serious adverse events were reported (one hyperkalemia and one decreased white blood cell count).</p>Conclusion<p>This real-world study supports the effectiveness and safety of serplulimab-based regimens as a first-line treatment for patients with locally advanced or metastatic esophageal cancer, regardless of their diverse characteristics.…”
-
718
-
719
-
720